Weighing in on glucagon-like peptide-1 receptor agonists in dermatology.

Heymann, Warren R

Heymann, Warren R.

Affiliation

Heymann WR; Division of Dermatology, Cooper Medical School of Rowan University, Camden, New Jersey. Electronic address: wrheymann@gmail.com.

J Am Acad Dermatol ; 91(1): 29-30, 2024 Jul.

Article in En | MEDLINE | ID: mdl-38692437

Subject(s)

Glucagon-Like Peptide-1 Receptor Agonists; Hypoglycemic Agents; Humans; Dermatology; Glucagon-Like Peptide-1 Receptor Agonists/adverse effects; Glucagon-Like Peptide-1 Receptor Agonists/therapeutic use; Hypoglycemic Agents/adverse effects; Hypoglycemic Agents/therapeutic use; Skin Diseases/drug therapy

Key words

glucagon-like peptide-1 receptor agonists; semaglutide; tirzepatide

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Glucagon-Like Peptide-1 Receptor Agonists / Hypoglycemic Agents Limits: Humans Language: En Journal: J Am Acad Dermatol Year: 2024 Document type: Article Publication country: EEUU / ESTADOS UNIDOS / ESTADOS UNIDOS DA AMERICA / EUA / UNITED STATES / UNITED STATES OF AMERICA / US / USA

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google